Log in
Enquire now
‌

AgomAb (Company)

Agonistic monoclonal antibody molecules

OverviewStructured DataIssuesContributors

Contents

agomab.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Liver disease
Liver disease
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Health technology
Health technology
Therapeutics
Therapeutics
Biotechnology
Biotechnology
Endocrine disease
Endocrine disease
...
Location
Belgium
Belgium
B2X
B2B
B2B
0
CEO
‌
Tim Knotnerus
0
Pitchbook URL
pitchbook.com/profiles...266527-81
Number of Employees (Ranges)
11 – 500
Email Address
tim.knotnerus@agomab.com
Investors
Redmile Group
Redmile Group
Pontifax Venture Capital
Pontifax Venture Capital
Omnes Group
Omnes Group
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
V-Bio Ventures
V-Bio Ventures
Advent France Biotechnology
Advent France Biotechnology
BIVF
BIVF
Omnes Capital
Omnes Capital
...
Founded Date
2017
0
Total Funding Amount (USD)
97,600,000
Latest Funding Round Date
March 10, 2021
CTO
‌
Torsten Dreier
0
Also Known As
AgomAb Therapeutics
Latest Funding Type
Series B
Series B
Country
Belgium
Belgium
Headquarters
Ghent
Ghent

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
74,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like AgomAb (Company)

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.